• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options

9781536119800
1 385,94 zł
1 247,34 zł Zniżka 138,60 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 247,34 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book focuses on risk factors, clinical and biological characteristics, and treatment options for depression. The aim of this book is to provide readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression as well as promising treatment for depression. The book is divided into five sections, the first of which examines the clinical heterogeneity of depression. Clinical symptoms, risk factors and treatment options of depression during neurodevelopment and neurodegeneration periods differ from those of depression in adults. Section II highlights bio-psychosocial factors in depression. Major depression cannot be understood without considering the psychosocial environment. Interaction between genetic susceptibility and the psychosocial context affect the occurrence of major depression. Section III focuses on biomarkers of depression. It covers from the overview of biomarkers, focusing on diagnosis, subtyping of depression and treatment response prediction to neuroimaging, genetics, and serum markers in depression. Section IV covers neurobiology and management for treatment-resistant depression. It discusses the etiological issues of treatment-resistant depression including genetic susceptibility, structural and functional MRI markers, neurogenesis, neuroinflammation and neuromodulation treatment for treatment-resistant depression. Section V highlights new perspectives of depression. Neurotrophic hypothesis-driven BDNF-TrkB signalling pathways and downstream of neurotransmitters have attracted attention to new pharmacologic targets. Homeostatic regulation of sleep, its dysregulation in mood disorders, and updated theories between inflammations and depression are discussed. The book will provide a better understanding of clinical and biological features and the management of depression, and will also function as a step onto the path toward the ultimate goal of predicting, preventing and treating depression.
Szczegóły produktu
72433
9781536119800
9781536119800

Opis

Rok wydania
2017
Numer wydania
1
Oprawa
twarda
Liczba stron
330
Wymiary (mm)
180.00 x 260.00
Waga (g)
754
  • Preface; Risk Factors, Clinical Characteristics, & Treatment Options of Depressive Disorders in Children & Adolescents; Risk Factors & Clinical Characteristics of Old-Age Depression; Major Depressive Disorder & Vascular Diseases:: The Unbearable Lightness of Bidirectionality; Issues in the Classification of Psychotic Depression; Bio-Psycho-Social Risk Factors for Depression; Suicide Risk Factors & Prevention Programs in Major Depressive Disorder; Neurobiology & Treatment Options of Major Depressive Disorder in Suicidal Situations; Diagnosis & Prognosis of Major Depressive Disorder:: From Clinical to Biological Applications; Structural Neuroimaging Studies in Major Depressive Disorder:: Progress toward a Biomarker for Depression; Biomarkers of Treatment Response in Depression; Treatment-Resistant Depression:: Neurobiological Etiology & Pharmacological Treatment Strategies; Neuromodulation for Treatment-Refractory Depression; BDNF Receptor TrkB as a Target of Antidepressants; Updated Theories between Inflammations & Major Depression; Index.
Komentarze (0)